Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE‐MI): design and baseline characteristics

European Journal of Heart Failure(2021)10.1002/ejhf.2191Source: DataRank Database

Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE‐MI): design and baseline characteristics is a research paper published in European Journal of Heart Failure (2021). On theSindex it has a DataRank of 0. It has been cited 109 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access109 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: bronzeTopics (53)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Brian Claggett ORCID,Marc A. Pfeffer ORCID,Christopher B. Granger ORCID,Lars Køber ORCID,Eldrin F. Lewis

Live enrichment

PubMed:33847047

NHLBI NIH HHS

Grant: T32 HL007604

National Institutes of Health

Grant: 2T32HL007604-06

TRAINING PROGRAM IN CARDIOVASCULAR RESEARCH

bronzeLicense: Wiley Online Library User Agreement

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ejhf.2191

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2191

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/ejhf.2191

repositoryhttps://research.rug.nl/en/publications/426dccdc-5175-45ca-a003-bf3ebb682dd7

repositoryhttp://eprints.gla.ac.uk/239197/

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansMyocardial InfarctionTetrazolesDrug CombinationsAngiotensin-Converting Enzyme InhibitorsStroke VolumeProspective StudiesVentricular Function, LeftAgedMiddle AgedFemaleHeart FailureAngiotensin Receptor AntagonistsAminobutyratesEquivalence Trials as Topic

Keywords

Acute myocardial infarctionHeart Failureangiotensin-converting enzyme inhibitorAngiotensin Receptor-neprilysin InhibitorSacubitril/valsartanAngiotensin receptor&#8211Myocardial InfarctionTetrazolesAngiotensin-Converting Enzyme InhibitorsEquivalence Trials as TopicCONVERTING-ENZYME INHIBITORconverting enzyme inhibitorvalsartanVentricular Function, LeftNEPRILYSIN INHIBITIONMORBIDITYAngiotensin Receptor AntagonistsLEFT-VENTRICULAR DYSFUNCTIONneprilysin inhibitorMANAGEMENTHumansST-SEGMENT ELEVATIONProspective StudiesAgedAngiotensin receptor–neprilysin inhibitorMORTALITYAminobutyratesStroke VolumeAngiotensin&#8208Middle AgedSacubitrilDrug CombinationsSURVIVALCAPTOPRILFemaleTASK-FORCE

Sustainable Development Goals

SDG 3: 3. Good health